Jennifer G. Abelin, Ph.D. - Publications

Affiliations: 
2013 Chemistry University of Virginia, Charlottesville, VA 
Area:
Analytical Biochemistry

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Weingarten-Gabbay S, Chen DY, Sarkizova S, Taylor HB, Gentili M, Hernandez GM, Pearlman LR, Bauer MR, Rice CM, Clauser KR, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC. The HLA-II immunopeptidome of SARS-CoV-2. Cell Reports. 43: 113596. PMID 38117652 DOI: 10.1016/j.celrep.2023.113596  0.421
2023 Weingarten-Gabbay S, Chen DY, Sarkizova S, Taylor HB, Gentili M, Pearlman LR, Bauer MR, Rice CM, Clauser KR, Hacohen N, Carr SA, Abelin JG, Saeed M, Sabeti PC. The HLA-II immunopeptidome of SARS-CoV-2. Biorxiv : the Preprint Server For Biology. PMID 37398281 DOI: 10.1101/2023.05.26.542482  0.429
2023 Stražar M, Park J, Abelin JG, Taylor HB, Pedersen TK, Plichta DR, Brown EM, Eraslan B, Hung YM, Ortiz K, Clauser KR, Carr SA, Xavier RJ, Graham DB. HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery. Immunity. PMID 37301199 DOI: 10.1016/j.immuni.2023.05.009  0.458
2023 Phulphagar KM, Ctortecka C, Jacome ASV, Klaeger S, Verzani EK, Hernandez GM, Udeshi ND, Clauser KR, Abelin JG, Carr SA. Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry. Molecular & Cellular Proteomics : McP. 100563. PMID 37142057 DOI: 10.1016/j.mcpro.2023.100563  0.676
2023 Abelin JG, Bergstrom EJ, Rivera KD, Taylor HB, Klaeger S, Xu C, Verzani EK, Jackson White C, Woldemichael HB, Virshup M, Olive ME, Maynard M, Vartany SA, Allen JD, Phulphagar K, et al. Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues. Nature Communications. 14: 1851. PMID 37012232 DOI: 10.1038/s41467-023-37547-0  0.668
2023 Phulphagar KM, Ctortecka C, Vaca Jacome AS, Klaeger S, Verzani EK, Hernandez GM, Udeshi N, Clauser K, Abelin J, Carr SA. Sensitive, high-throughput HLA-I and HLA-II immunopeptidomics using parallel accumulation-serial fragmentation mass spectrometry. Biorxiv : the Preprint Server For Biology. PMID 36993564 DOI: 10.1101/2023.03.10.532106  0.676
2022 Weingarten-Gabbay S, Pearlman LR, Chen DY, Klaeger S, Taylor HB, Welch NL, Keskin DB, Carr SA, Abelin JG, Saeed M, Sabeti PC. HLA-I immunopeptidome profiling of human cells infected with high-containment enveloped viruses. Star Protocols. 3: 101910. PMID 36595954 DOI: 10.1016/j.xpro.2022.101910  0.316
2021 Choi J, Goulding SP, Conn BP, McGann CD, Dietze JL, Kohler J, Lenkala D, Boudot A, Rothenberg DA, Turcott PJ, Srouji JR, Foley KC, Rooney MS, van Buuren MM, Gaynor RB, ... Abelin JG, et al. Systematic discovery and validation of T cell targets directed against oncogenic KRAS mutations. Cell Reports Methods. 1: 100084. PMID 35474673 DOI: 10.1016/j.crmeth.2021.100084  0.49
2021 Penny SA, Abelin JG, Malaker SA, Myers PT, Saeed AZ, Steadman LG, Bai DL, Ward ST, Shabanowitz J, Hunt DF, Cobbold M. Tumor Infiltrating Lymphocytes Target HLA-I Phosphopeptides Derived From Cancer Signaling in Colorectal Cancer. Frontiers in Immunology. 12: 723566. PMID 34504498 DOI: 10.3389/fimmu.2021.723566  0.775
2021 Klaeger S, Apffel A, Clauser KR, Sarkizova S, Oliveira G, Rachimi S, Le PM, Tarren A, Chea V, Abelin JG, Braun DA, Ott PA, Keshishian H, Hacohen N, Keskin DB, et al. Optimized liquid and gas phase fractionation increases HLA-peptidome coverage for primary cell and tissue samples. Molecular & Cellular Proteomics : McP. 100133. PMID 34391888 DOI: 10.1016/j.mcpro.2021.100133  0.323
2021 Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Gallagher KME, Bauer MR, Taylor HB, Dunn WA, Tarr C, Sidney J, Rachimi S, Conway HL, Katsis K, Wang Y, ... ... Abelin JG, et al. Profiling SARS-CoV-2 HLA-I peptidome reveals T cell epitopes from out-of-frame ORFs. Cell. PMID 34171305 DOI: 10.1016/j.cell.2021.05.046  0.495
2021 Taylor HB, Klaeger S, Clauser KR, Sarkizova S, Weingarten-Gabbay S, Graham DB, Carr SA, Abelin JG. Mass spectrometry-based HLA-II peptidomics combined with multi-omics will aid the development of future immunotherapies. Molecular & Cellular Proteomics : McP. 100116. PMID 34146720 DOI: 10.1016/j.mcpro.2021.100116  0.538
2020 Weingarten-Gabbay S, Klaeger S, Sarkizova S, Pearlman LR, Chen DY, Bauer MR, Taylor HB, Conway HL, Tomkins-Tinch CH, Finkel Y, Nachshon A, Gentili M, Rivera KD, Keskin DB, Rice CM, ... ... Abelin JG, et al. SARS-CoV-2 infected cells present HLA-I peptides from canonical and out-of-frame ORFs. Biorxiv : the Preprint Server For Biology. PMID 33024965 DOI: 10.1101/2020.10.02.324145  0.466
2019 Abelin JG, Harjanto D, Malloy M, Suri P, Colson T, Goulding SP, Creech AL, Serrano LR, Nasir G, Nasrullah Y, McGann CD, Velez D, Ting YS, Poran A, Rothenberg DA, et al. Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction. Immunity. PMID 31495665 DOI: 10.1016/J.Immuni.2019.08.012  0.484
2018 Graham DB, Luo C, O'Connell DJ, Lefkovith A, Brown EM, Yassour M, Varma M, Abelin JG, Conway KL, Jasso GJ, Matar CG, Carr SA, Xavier RJ. Antigen discovery and specification of immunodominance hierarchies for MHCII-restricted epitopes. Nature Medicine. PMID 30349087 DOI: 10.1038/S41591-018-0203-7  0.519
2018 Creech AL, Ting YS, Goulding SP, Sauld JF, Barthelme D, Rooney MS, Addona TA, Abelin JG. The role of mass spectrometry and proteogenomics in the advancement of HLA epitope prediction. Proteomics. PMID 29314742 DOI: 10.1002/pmic.201700259  0.321
2017 Abelin JG, Keskin DB, Sarkizova S, Hartigan CR, Zhang W, Sidney J, Stevens J, Lane W, Zhang GL, Eisenhaure TM, Clauser KR, Hacohen N, Rooney MS, Carr SA, Wu CJ. Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction. Immunity. 46: 315-326. PMID 28228285 DOI: 10.1016/J.Immuni.2017.02.007  0.309
2016 Ager C, Reilley M, Nicholas C, Bartkowiak T, Jaiswal A, Curran M, Albershardt TC, Bajaj A, Archer JF, Reeves RS, Ngo LY, Berglund P, ter Meulen J, Denis C, Ghadially H, ... ... Abelin JG, et al. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two Journal For Immunotherapy of Cancer. 4. DOI: 10.1186/S40425-016-0173-6  0.491
2016 Penny S, Abelin J, Saeed A, Malaker S, Trantham P, Shabanowitz J, Ward S, Hunt D, Cobbold M. Phosphopeptides as novel tumour antigens in colorectal cancer European Journal of Cancer. 61: S213. DOI: 10.1016/S0959-8049(16)61751-3  0.522
2015 Abelin JG, Trantham PD, Penny SA, Patterson AM, Ward ST, Hildebrand WH, Cobbold M, Bai DL, Shabanowitz J, Hunt DF. Complementary IMAC enrichment methods for HLA-associated phosphopeptide identification by mass spectrometry. Nature Protocols. 10: 1308-18. PMID 26247297 DOI: 10.1038/Nprot.2015.086  0.677
2014 Penny SA, Abelin JG, Saeed AZ, Malaker SA, Trantham PD, Shabanowitz J, Ward ST, Hunt DF, Cobbold M. Abstract 3627: Phosphopeptides as novel T cell epitopes in colorectal cancer Cancer Research. 74: 3627-3627. DOI: 10.1158/1538-7445.Am2014-3627  0.769
2013 Cobbold M, De La Peña H, Norris A, Polefrone JM, Qian J, English AM, Cummings KL, Penny S, Turner JE, Cottine J, Abelin JG, Malaker SA, Zarling AL, Huang HW, Goodyear O, et al. MHC class I-associated phosphopeptides are the targets of memory-like immunity in leukemia. Science Translational Medicine. 5: 203ra125. PMID 24048523 DOI: 10.1126/Scitranslmed.3006061  0.314
Show low-probability matches.